Carbonic anhydrase inhibitors and their therapeutic potential

CT Supuran, A Scozzafava - Expert Opinion on Therapeutic Patents, 2000 - Taylor & Francis
Carbonic anhydrases (CAs, EC 4.2. 1.1) are wide-spread zinc enzymes, present in archaeo-
and eubacteria, algae, green plants and animals. Within these organisms CAs are encoded …

Acute mountain sickness: pathophysiology, prevention, and treatment

C Imray, A Wright, A Subudhi, R Roach - Progress in cardiovascular …, 2010 - Elsevier
Barometric pressure falls with increasing altitude and consequently there is a reduction in
the partial pressure of oxygen resulting in a hypoxic challenge to any individual ascending …

Burger's medicinal chemistry and drug discovery

ME Wolff - American Journal of Therapeutics, 1996 - journals.lww.com
American Journal of Therapeutics Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Acute mountain sickness in a general tourist population at moderate altitudes

B Honigman, MK Theis, J Koziol-McLain… - Annals of internal …, 1993 - acpjournals.org
Objective: To determine the incidence of acute mountain sickness in a general population of
visitors to moderate elevations, the characteristics associated with it, and its effect on …

[PDF][PDF] Nifedipine and amlodipine are associated with improved mortality and decreased risk for intubation and mechanical ventilation in elderly patients hospitalized …

I Solaimanzadeh - Cureus, 2020 - cureus.com
Dihydropyridine calcium channel blockers (CCB) are typically used agents in the clinical
management of hypertension. Yet, they have also been utilized in the treatment of various …

[PDF][PDF] Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease …

I Solaimanzadeh - Cureus, 2020 - cureus.com
Effective treatments for Coronavirus Disease 2019 (COVID-19) outbreak are urgently
needed. While anti-viral approaches and vaccines are being considered immediate …

Prevalence of acute mountain sickness in the Swiss Alps.

M Maggiorini, B Bühler, M Walter, O Oelz - British Medical Journal, 1990 - bmj.com
OBJECTIVE--To assess the prevalence of symptoms and signs of acute mountain sickness
of the Swiss Alps. DESIGN--A study using an interview and clinical examination in a …

[HTML][HTML] Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness

DE Leaf, DS Goldfarb - Journal of applied physiology, 2007 - journals.physiology.org
Acetazolamide, a potent carbonic anhydrase (CA) inhibitor, is the most commonly used and
best-studied agent for the amelioration of acute mountain sickness (AMS). The actual …

Exercise exacerbates acute mountain sickness at simulated high altitude

RC Roach, D Maes, D Sandoval… - Journal of applied …, 2000 - journals.physiology.org
.—We hypothesized that exercise would cause greater severity and incidence of acute
mountain sickness (AMS) in the early hours of exposure to altitude. After passive ascent to …

High-altitude exposures and intestinal barrier dysfunction

ZJ McKenna, F Gorini Pereira… - American Journal …, 2022 - journals.physiology.org
Gastrointestinal complaints are often reported during ascents to high altitude (> 2,500 m),
though their etiology is not known. One potential explanation is injury to the intestinal barrier …